You did not need a research note to see the stress on June 24. You just needed two columns of the tape:
| Asset (intraday, ~12:00 ET Jun 24) | Price | Day | Read |
|---|---|---|---|
| SPY (S&P 500 ETF) | $738.37 | +0.65% | Broad market up |
| Apollo (APO) | $126.18 | -3.39% | GP fee-stream repricing |
| BlackRock (BLK) | $983.29 | -3.16% | DOJ probe + redemptions |
| Blackstone (BX) | $116.34 | -3.11% | BCRED gate overhang |
| Ares Mgmt (ARES) | $117.70 | -2.55% | ASIF gate overhang |
| KKR | $92.30 | -1.28% | FSK junk downgrade |
| Ares Capital (ARCC) — listed BDC | $18.00 | +0.61% | Public credit green |
| Blue Owl Capital Corp (OBDC) — listed BDC | $10.85 | +0.46% | Public credit green |
| Blackstone Secured Lending (BXSL) | $23.86 | +0.97% | Public credit green |
The alternative-asset managers are down ~3% on a day the S&P is up. This is not random. Two fresh catalysts landed inside the last 12 days:
Trace the chronology and the trajectory is unmistakable. Q1 gates clustered at ~11% requests (Apollo 11.2%, Ares 11.6%, Morgan Stanley 11%, Barings 11.3%). Q2 requests are running 13–17% (Apollo 16.8%, BlackRock 13.3%, Cliffwater 17%, BofA projected Blue Owl OTIC as high as 52.9%). The gates did not solve the run — they postponed it, and the postponed demand is compounding.
The instinct is to treat a deep discount as the danger sign and a stable NAV as safety. In private credit, the polarity is reversed. Here is why:
A listed BDC has a public stock price that marks it to reality every second. A non-traded BDC has a NAV set quarterly by the same manager that collects fees on that NAV — and that you can only exit through a 5% gate.
That is the entire problem in one sentence. When BlackRock's listed TCP Capital (TCPC) filed a rare off-cycle disclosure in January slashing asset values 19% (NAV $8.71 → $7.07), the stock fell 13% in a day and now trades near $3.24 — a ~54% discount to a NAV that is itself suspect. The Manhattan U.S. Attorney's office (SDNY) is now probing TCPC's valuation practices, with executives questioned. SDNY chief Jay Clayton's framing is the tell: “if people are mismarking in order to generate fees, that's always been a no-no.”
The discount on the good listed BDCs is the market doing the regulator's job in advance. The flat NAV on the gated non-traded funds is the absence of that mechanism. The danger is not where the price has already fallen; it is where the price cannot fall because there is no price.
| Metric | Figure | Source / date | Consequence |
|---|---|---|---|
| Fitch Private Credit Default Rate (TTM) | 6.0% (record) | Fitch, for 12M ended Apr 2026 | Highest in the series' history |
| Moody's “true” vs headline default | 4.7% vs 1.6% | Moody's, May 20 | Distressed exchanges mask ~3x the stress |
| Distressed-exchange share of downgrades to D/SD | 94% | Morningstar DBRS, 12M to Feb 2026 | Defaults are being “amended”, not cured |
| Q1 2026 BDC unrealized losses | 2.35% of NAV | steepest since Q2 2022 | Marks finally catching down |
| BDC capital formation | −40% YoY (Q1) | sharpest contraction on record | Growth engine stalled |
| U.S. life-insurer private-credit exposure | $807B (+$122B in 2025) | Moody's, Jun 8 | The real contagion vector (see §5) |
| U.S. bank lending to NDFIs / private credit | ~$1.2T / ~$300B | Moody's, Oct 2025 | Regional banks ~$100–150B (Hedgeye) |
Fitch's April peer review of 12 rated BDCs set its 2026 sector outlook to “deteriorating”, citing pressure on net investment income, dividend coverage below 100% for 11 rated BDCs, PIK income at 8.1% of investment income, and the risk that secured facilities get tapped to fund both 2026 debt maturities and redemptions. Translation: the funding-and-payout math is tightening from both ends.
My core view, unchanged from Monday and reinforced by today's tape: this is a liquidity-and-marks event concentrated in non-traded vehicles and the GP fee stream — not a solvency event in senior-secured listed credit. The listed BDC universe is ~96% floating-rate, ~78% senior secured, levered ~1.0–1.25x, with gates and asset-coverage tests. The right response is not “avoid private credit” — it is to sort ruthlessly.
OBDC (Blue Owl Capital Corp) — HIGH CONVICTION, top pick. Price $10.85 vs NAV/share $14.41 = a ~25% discount; yield ~11.4% on the reset $0.31 quarterly base dividend.
Trade: accumulate $10.40–11.00, add <$10.50. Target $12.75 (1–3mo), $13.31 (6–12mo, analyst avg). Invalidation: weekly close <$9.80 OR a fresh cluster of non-accruals dragging NAV <$13.75. Catalyst: Blue Owl shareholder meeting June 25.
ARCC (Ares Capital) — CORE holding, MEDIUM-HIGH conviction. Price $18.00 vs NAV ~$19.5 = ~8% discount; yield 10.7%; P/E ~11.2x ttm. Best-of-breed scale ($12.8B cap), most diversified book, low direct software exposure, 3-yr EPS growth +17%, launched a $1B commercial-paper program (Jun 8) backed by a $5.5B revolver. Got a fresh sell-side “Strong Buy” upgrade this morning citing the ~11% yield, discount to book and low non-accruals.
Trade: accumulate $17.25–18.25. Target $20 (6–12mo). Invalidation: weekly close <$16. The smaller discount vs OBDC is the price of its superior quality — own both, size OBDC for the discount, ARCC for the sleep-at-night.
| Name | Price | Why avoid |
|---|---|---|
| TCPC (BlackRock TCP) | $3.24 | DOJ valuation probe, executives questioned, securities class actions, NAV cut to $7.07 and Bloomberg-tracked estimates point to ~$6.76 by year-end. A 54% “discount” to a NAV nobody trusts is not value — it is a legal call option. Uninvestable until the probe clears. |
| FSK (FS KKR Capital) | $10.21 | Moody's cut to junk (Ba1) in March; non-accruals ~5.5%; dividend cut $0.70→$0.48; KKR running a $300M buyback and fee waivers to defend it. Down ~28% YTD. The opposite of OBDC's credit profile. |
| Non-traded BDCs (BCRED, ADS, HLEND, OBDC II, OCIC/OTIC) | — | This is the epicenter. Gated, pro-rated to ~30–45% of requests, queues compounding into Q3. You cannot get your money out at NAV; the NAV itself is the question. If you hold these, your liquidity is the manager's discretion. |
Today's 3% drop in the alt managers is the market repricing a structural truth: their fastest-growing profit engine over the last five years was the retail non-traded wrapper, and that engine is now running in reverse — capital formation −40% YoY, redemptions accelerating, and BDC management fees scaling down with shrinking, gated AUM. My honest read: the GP repricing is not finished. Apollo is down ~22% YTD, the group has at times traded 25%+ below the S&P. These are world-class franchises and I would not short them — but I would not catch this falling knife on a “quality-at-a-discount” reflex either. The one genuine offset is the 401(k)/retirement-channel opening (EO 14330 + DoL safe-harbor) that could route ~$178B of new alts demand into target-date funds over time — a multi-year story, not a Q3 catalyst. WATCH; revisit BX/APO on a capitulation flush or the first quarter redemptions actually decelerate.
This is unfolding into a hawkish-Fed window. Core PCE prints tomorrow (Jun 25, 8:30am ET); the consensus whisper near +0.37% m/m would push a Warsh October hike from tail risk toward base case. Higher-for-longer is a double hit to this complex: it keeps refinancing costs elevated for over-levered borrowers and it sustains the very base-rate/spread dynamics squeezing BDC net investment income. A hot PCE is incrementally bearish for FSK-type impaired credit and the GP fee stream; it is largely already in the price for OBDC/ARCC at 25%/8% discounts. High-yield (HYG ~$79.97) is notably calm — public credit spreads are not confirming the private-credit stress, which is either complacency or confirmation that this is contained to the opaque, retail-funded corner. I lean toward “contained, but mispriced.”
| Scenario | Prob. | Trigger | Playbook |
|---|---|---|---|
| Base — Slow-motion dispersion | 55% | Q2 redemptions stay 13–17%, gates hold, listed-BDC credit stable (non-accruals <2% FV), no major BDC dividend collapse. | OBDC/ARCC discounts compress as NAV stabilizes & buybacks bite. Total return 12–20% over 6–12mo via yield + discount close. GP names drift, no V-recovery. |
| Bull — The washout bottoms | 20% | PCE cools, Fed off the table, Q3 redemption requests decelerate, a marquee non-traded fund honors in full. | OBDC to $12.75–13.31, ARCC to $20+. GP names (BX/APO) rip 20–30% off the lows — the WATCH list converts to BUY. |
| Bear — Liquidity becomes solvency | 25% | A second First-Brands/Tricolor-style fraud or a forced insurer markdown; software/AI loan losses spike; a non-traded fund suspends entirely (OBDC II precedent). | Everything de-rates 15–30%; listed BDCs revisit April lows (OBDC ~$10.20, ARCC ~$17.40). Invalidations trigger — cut FSK/TCPC-type exposure to zero, hold OBDC/ARCC only if non-accruals stay contained. |
Thesis in one line: The private-credit “crisis” is real but mislocated — it lives in gated non-traded wrappers, suspect marks, and the GP fee stream, not in senior-secured listed credit, where 25% discounts already pay you to wait.
Position sizing (my opinion): a quality listed-BDC sleeve of 3–6% of an income portfolio split ~60/40 OBDC/ARCC is a reasonable way to harvest an 11% yield plus a discount-closure kicker, with the gates-and-frauds risk explicitly fenced off by avoiding the non-traded and impaired names. This is income with a catalyst, not a hero trade.
Key linked sources:
OBDC Q1 2026 results (primary, press release + financials) ·
Fitch peer review of 12 US BDCs (Apr 9, 2026) ·
FSB Report on Vulnerabilities in Private Credit (May 6, 2026) ·
Fortune/Bloomberg — DOJ probes BlackRock TCPC valuations ·
With Intelligence — Apollo & Ares cap redemptions ·
CNBC — Dimon on credit-recession risk ·
Yardeni Private Credit Monitor (event chronology).
This is analysis and opinion for general information, not individualized investment advice. The author may hold or initiate positions in securities discussed. Prices are intraday June 24, 2026 and will change. Do your own diligence.